Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
04/2007
04/03/2007US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators
04/03/2007US7199113 Inhibiting tissue factor-dependent activation of blood-coagulation factors X or IX by contacting the tissue factor with a bisphosphonate blocking agent; anticoagulation
04/03/2007US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis
04/03/2007CA2183430C Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
04/03/2007CA2162397C Ligands for flt3 receptors
03/2007
03/29/2007WO2007035406A1 Antibodies to complementary peptides of thrombin or portions thereof
03/29/2007US20070072869 CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS
03/29/2007US20070072826 Compositions and methods for modulation of vascular structure and/or function
03/29/2007US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors
03/29/2007US20070071812 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
03/29/2007DE102005045518A1 New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
03/28/2007EP1767634A1 Novel galectin 8 modification protein and use thereof
03/28/2007EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists
03/28/2007EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds
03/28/2007EP1765411A2 Polymer-factor ix moiety conjugates
03/28/2007EP1765324A2 Compositions of stable bioactive metabolites of docosahexaenoic (dha) and eicosapentaenoic (epa) acids
03/28/2007EP1254944B1 Dry compositions containing hydrophobic amino acid
03/28/2007CN1938294A Novel pyrrolidine-3,4-dicarboxamide derivatives
03/28/2007CN1938269A Prolinyl derivatives for treating thrombosis
03/28/2007CN1938058A Solid pharmaceutical preparation for dialysis
03/28/2007CN1935823A Novel compound neopuerarin A and its separating method
03/28/2007CN1935277A Preparation for the prophylaxis of restenosis
03/28/2007CN1935260A Human antibodies that bind human tnfalpha
03/28/2007CN1935235A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935234A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935233A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935232A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935231A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935230A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935229A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935221A Medicinal liquor for treating malignant boil
03/28/2007CN1935199A Quality control method for Chinese medicine compound preparation
03/28/2007CN1935188A Method for preparing injection agent for promoting blood circulation
03/28/2007CN1935185A Animal medicament with activating blood to promote menstruation, inducing diuresis to reduce edema, and its preparing method
03/28/2007CN1935178A Ginkgo leaf extract and barrenwort extract composition
03/28/2007CN1935154A Pharmaceutical use of fucoidan for treating cardio-cerebrovascular disease
03/28/2007CN1935124A Tetramethylpyrazine phosphate slow-release micro-pill and its preparing method
03/28/2007CN1935119A Clopidogrel sulfate solid preparation, and its preparing method
03/28/2007CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog
03/28/2007CN1307174C Imidazoquinoline derivatives
03/28/2007CN1307172C 喹唑啉酮衍生物 Quinazolinone derivative
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
03/28/2007CN1306963C Remedy for diseases caused by IL-6 production
03/28/2007CN1306932C Medication for lowering level of endotoxin in human blood
03/27/2007US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
03/27/2007US7196118 Amidino compounds useful as nitric oxide synthase inhibitors
03/27/2007US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases
03/27/2007US7196103 Indole derivatives as factor Xa inhibitors
03/27/2007US7196076 Androgen receptor modulators and methods of use thereof
03/27/2007US7196063 Peptides and pharmaceutical compositions comprising same
03/27/2007US7195903 Comprises metallloenzyme which is fibrinolytically active (fibrolase), for use in treating blood clots in situ
03/27/2007US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders
03/27/2007US7195870 Diagnosis of diseases associated with gene regulation
03/27/2007US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
03/27/2007US7195640 Coated medical devices for the treatment of vulnerable plaque
03/27/2007CA2326611C Substituted heterocyclic derivatives
03/27/2007CA2084552C Novel synthetic isohirudins with improved stability
03/22/2007WO2007032566A1 Hematopoietic stem cell proliferator
03/22/2007WO2007032557A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
03/22/2007WO2007032466A1 Heterocyclic compound, and production process and use thereof
03/22/2007WO2006091847A3 Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
03/22/2007WO2006016424A8 Preventive and/or therapeutic agent for calcipenia
03/22/2007US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases
03/22/2007US20070066539 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof
03/22/2007US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells
03/22/2007US20070065921 Methods and products related to producing low molecular weight heparin
03/22/2007US20070065485 Therapeutic delivery of carbon monoxide
03/22/2007DE102005044319A1 2-(Aminomethyl)-5-Chlor-Benzylamid-Derivate und ihre Verwendung als Hemmstoffe des Gerinnungsfaktors Xa 2- (Aminomethyl) -5-chloro-benzylamide derivatives and their use as inhibitors of coagulation factor Xa
03/22/2007CA2622605A1 Heterocycle compound, and production process and application thereof
03/22/2007CA2622575A1 Prok2 antagonists and methods of use
03/22/2007CA2620296A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
03/21/2007EP1764366A2 Thrombin receptor antagonists
03/21/2007EP1764075A1 Tissue factor production inhibitor
03/21/2007EP1763521A1 1- (indole-6-carbonyl-d-phenylglycinyl)-4- (l-methylpiperidin-4- yl) piperazine d-tartrate
03/21/2007EP1696940B1 A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma
03/21/2007EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
03/21/2007EP1448052B1 Anti-pathogenic composition useful in blood preservation
03/21/2007EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same
03/21/2007EP1331228B1 Method of screening antiplatelet
03/21/2007EP1303305B1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
03/21/2007EP1216259B1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium
03/21/2007EP0907724B1 Von willebrand factor multimerase
03/21/2007CN1934252A Thrombin derivatives and medicinal composition containing the same
03/21/2007CN1934122A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
03/21/2007CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
03/21/2007CN1933729A Pesticidal composition
03/21/2007CN1931878A Platelet aggregation resistant chimeric monoclonal antibody and/or its fragment
03/21/2007CN1931875A High purity ulinastatin and its prepn process and medicine composition
03/21/2007CN1931361A Prepn process of blood-nourishing and iron-replenishing health nutrient
03/21/2007CN1931336A Chinese medicine composition and its prepn process
03/21/2007CN1931293A Oil-in-water type nanometer grassleaved sweetflag oil emulsion oral liquid and its prepn process
03/21/2007CN1931266A Medicine composition for treating leukopenia and its prepn process
03/21/2007CN1931255A Medicine for treating thrombocytopenia and anemia and its prepn process and quality control method
03/21/2007CN1931248A Medicine composition and its prepn process
03/21/2007CN1931234A Medicine composition of red sage and puerarin
03/21/2007CN1931233A Medicine composition of red sage and epimedium for treating cardiac and cerebral vascular diseases
03/21/2007CN1931228A Lysimachia herb total flavone extract and its prepn process
03/21/2007CN1931227A Prepn process of externally applied Chinese clinopodium herb prepn
03/21/2007CN1931214A Medicine composition of rhodiola root and puerarin
03/21/2007CN1931182A Health food for preventing and treating cardiac and cerebral vascular diseases and its production process